---
layout: post
title: "Advisory Committee; Vaccines and Related Biological Products Advisory Committee; Renewal"
date: 2026-02-05 18:57:54 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-01858
original_published: 2022-01-31 00:00:00 +0000
significance: 8.00
---

# Advisory Committee; Vaccines and Related Biological Products Advisory Committee; Renewal

**Published:** February 05, 2026 18:57 UTC
**Source:** Federal Register
**Original Published:** January 31, 2022 00:00 UTC
**Document Number:** 2022-01858

## Summary

The Food and Drug Administration (FDA or the Agency) is announcing the renewal of the Vaccines and Related Biological Products Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Vaccines and Related Biological Products Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until the December 31, 2023, expiration date.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/01/31/2022-01858/advisory-committee-vaccines-and-related-biological-products-advisory-committee-renewal)
- API: https://www.federalregister.gov/api/v1/documents/2022-01858

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
